Continuum Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Continuum Advisory's LLY Position: Q1 2026 in Review
Continuum Advisory increased its Eli Lilly (LLY) stake by 16% in Q1 2026, buying an estimated $350K and bringing the position to 2,448 shares worth $2.25M. The position accounts for 0.22% of the portfolio, ranked #97.
Continuum Advisory first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.26M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Continuum Advisory held 2,448 shares of Eli Lilly worth $2.25M as of Q1 2026.
- Continuum Advisory bought 345 Eli Lilly shares in Q1 2026, an estimated $350K.
- Eli Lilly made up 0.22% of Continuum Advisory's portfolio in Q1 2026, its #97 holding.
- Continuum Advisory first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
- Continuum Advisory's Eli Lilly position peaked at $2.26M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Continuum Advisory's 13F filing for Q1 2026, filed 22 Apr 2026.